NCT02284386View on ClinicalTrials.gov

Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Pain
Interventions
DRUG

Bupivacaine SNB

SNB with a single 1.6 mL dose of bupivacaine HCl 7.5 mg/mL within 2 hours prior to the surgical procedure.

DRUG

EXPAREL Infiltration

Local infiltration of EXPAREL 266 mg into the surgical site at the end of the surgery just prior to wound closure.

Trial Locations (2)

35660

Shaols Medical Trials, Inc., Sheffield

55455

University of Minnesota Medical Center - Fairview, West Bank, Minneapolis

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY